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Abstract 
 
Neutrophils are essential innate immune cells that extrude chromatin in the form of 
neutrophil extracellular traps (NETs). This form of pro-inflammatory cell death has 
potent immunostimulatory activity. We show that heme-induced NETs are essential 
for malaria pathogenesis. Using patient samples and a mouse model, we define two 
mechanisms of NET-mediated inflammation of the vasculature: activation of 
emergency granulopoiesis via GCSF production, and induction of the endothelial 
cytoadhesion receptor ICAM-1. Soluble NET components facilitate Plasmodium 
sequestration and mediate tissue destruction. We demonstrate that neutrophils have 
a key role in triggering malaria immunopathology and propose inhibition of NETs as a 
treatment strategy in vascular infections. 
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Introduction 
 
Neutrophils are essential innate immune cells that circulate in the blood and 
respond to pathogens by phagocytosis, generation of oxidants and externalization of 
microbicidal peptides and proteases [1]. The release of these compartmentalized 
antimicrobials is achieved by either degranulation or the release of neutrophil 
extracellular traps (NETs). NETs consist of decondensed chromatin decorated with 
microbicidal and immunostimulatory molecules [2, 3]. NETs are released by a cell 
death program termed ‘NETosis’ and they ensure high local concentrations of active 
antimicrobials. Eventually, Deoxyribonuclease I (DNase 1), a constitutive plasma 
endonuclease, degrades NETs and facilitates their removal [4]. 
 NETosis is an active process that requires microbial or mitogenic signaling [5, 
6], the production of reactive oxygen species (ROS) [7], the activity of two serine 
proteases: neutrophil elastase (NE) and proteinase 3 (PR3) [8, 9] and the activation of 
the pore forming protein gasdermin D [10]. NE translocates from the granules to the 
nucleus during NET induction, where it cleaves histones to allow chromatin 
decondensation prior to plasma membrane breakdown [8]. NE and PR3 have partially 
overlapping substrates [11] and are both required for maximal NET induction in vivo 
[9].  
Triggering of NETosis by various microbes in tissues or the mucosa is thought to 
limit pathogen proliferation and dissemination. NET release inside the vasculature, 
however, can be pathogenic by triggering autoimmunity [12] and vasculitis [13], as well 
as directly damaging endothelia [14] and inducing thrombosis [15]. 
To understand the role of neutrophils in intravascular infections, we investigated 
malaria, a disease caused by protozoan parasites that invade red blood cells (RBCs) 
and trigger systemic neutrophil activation [16, 17]. Plasmodium falciparum is the most 
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important and virulent species, causing over 200 million malaria episodes and close to 
500,000 deaths annually [18] . It encompasses diverse pathological manifestations that 
can range from mild unspecific symptoms, fever and mild anemia to organ failure, 
acidosis, coma and death. Complications of severe malaria include cerebral malaria, 
acute respiratory distress syndrome, renal failure, placental malaria, liver damage and 
severe anemia [19]. 
Pathogenesis of P. falciparum malaria is precipitated by its interaction with the 
vascular endothelium. In the second half of the asexual erythrocytic lifecycle, parasites 
express cytoadhesion factors on the surface of infected RBCs (iRBCs), allowing 
binding and sequestration in postcapillary venules. Attachment and withdrawal from 
circulation is thought to aid in preventing clearance of iRBCs by splenic macrophages 
[20]. Disease severity is synergistically determined by sequestration patterns and host 
inflammatory responses [21, 22]. Cytoadhesion of iRBCs leads to endothelial 
activation and vascular occlusion [22], while release of pathogen- or danger- 
associated molecular pattern (PAMP or DAMP) molecules leads to pathological 
inflammatory responses mediated by cytokines such as tumor necrosis factor (TNF) 
and interleukin (IL)-1β [23]. Organ-specific iRBC sequestration is associated with 
corresponding pathology [21, 22]. 
Despite the important inflammatory component of the disease, the role of 
neutrophils in P. falciparum malaria remains unclear. Neutrophils isolated from malaria 
patients have a reduced capacity to mount an oxidative burst [24]. On the other hand, 
several studies have linked activation of these cells to pathogenesis and severe 
disease [16, 17, 25]. For instance, a recent blood transcriptomic analysis comparing 
severe and uncomplicated malaria identified a granulocyte colony stimulating factor 
(GCSF)-regulated neutrophil granulopoiesis signature as a specific feature of severe 
malaria [26]. Granulopoiesis refers to production of neutrophils from progenitor cells in 
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the bone marrow; this blood signature therefore identifies increased neutrophil 
abundance as a pathogenic factor in malaria. Furthermore, genes encoding neutrophil 
granule proteins, such as NE and matrix metalloproteinase-8 (MMP-8), showed the 
highest log-fold upregulation between severe and uncomplicated malaria [17]. 
Similarly, a study in Malawi by Feintuch et al. demonstrated that retinopathy-positive 
cerebral malaria is specifically associated with accumulation of externalized neutrophil 
proteins such as NE and PR3 [16]. Several studies in mouse models have also linked 
neutrophils to severe malaria [27-30]. 
In addition to the accumulation of soluble neutrophil proteases, severe disease is 
associated with an increase in extracellular human nucleosomes in patients’ plasma 
[31], which could indicate NET release. NETs are a platform for externalizing both 
nucleosomes and neutrophil proteases and could thus be an important pathogenic 
factor in malaria. Indeed, NETs were reported in mouse malaria [30] and NET-like 
structures were observed on patient blood smears [32].  
We show, using patient samples, that NETs are triggered by heme in malaria. 
We found NETs to be a source of immunostimulatory molecules - alarmins - that 
activate emergency hematopoiesis via GCSF induction. In a Plasmodium chabaudi 
chabaudi malaria model, host DNase 1 liberated neutrophil proteins from NETs and 
this release was required for neutrophilia and neutrophil infiltration in the liver. Soluble 
NET components were also required for parasite organ sequestration. Genetic 
depletion of NETs, or NET-processing DNase 1, reduced organ damage. We 
demonstrate an undescribed physiological role for NETs in circulation, as well as 
identify a potential target for adjunctive malaria therapy. 
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Results 
Intravascular NET formation in P. falciparum malaria 
To test if P. falciparum malaria is accompanied by bona fide NET induction, we 
analyzed plasma samples from forty-three parasitologically confirmed pediatric and 
adult patients, treated at the Albert Schweitzer Hospital, in Lambaréné, Gabon, a highly 
malaria-endemic region in Central Africa. The patients presented with variable disease 
severity, spanning from uncomplicated malaria to hyperparasitemia and severe 
anemia (Table S1). All patients recovered upon antimalarial treatment. NETs are 
defined as complexes of chromatin and neutrophil granule proteins; hence, we 
designed an ELISA that detects NETs with an anti-DNA detection antibody, preceded 
by a capture antibody against NE.  Notably, malaria patients had significantly elevated 
levels of NETs  compared to healthy controls from the same region (n = 9) (Fig. 1A).  
NET levels did not correlate with parasitemia or body temperature (data not shown). 
We also isolated peripheral blood neutrophils from hospitalized adult patients and 
monitored NET formation. Neutrophils from malaria patients (n = 8) released twofold 
more NETs than healthy controls (n = 6) (Fig. 1B). Importantly, NETs were released 
without the addition of exogenous stimuli, indicating that NETosis in malaria is 
activated in vivo. 
To confirm NET formation in the vasculature of organs affected by malaria, we 
detected NETs in a brain autopsy sample from a previously unexposed traveler with 
cerebral malaria. Using confocal imaging, we observed neutrophils in brain blood 
vessels where NE and chromatin colocalized (Fig. 1C), a reliable marker for early 
NETosis [8]. Together, these data indicate that NETs are induced in the bloodstream 
of malaria patients. 
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NETs in malaria are induced by heme and TNF 
To identify factors that trigger NET formation in malaria, we co-incubated neutrophils 
from healthy donors with P. falciparum cultures. Neutrophils were either primed with 
TNF, a major malaria-associated proinflammatory cytokine [22], or left unprimed. We 
exposed neutrophils to iRBCs, free merozoites, parasite digestive vacuoles, which are 
released upon RBC rupture and contain the hemozoin crystal, as well as heme, a 
known malaria DAMP that is released during parasite egress, as well as during 
‘bystander hemolysis’ – the inflammatory destruction of uninfected RBCs [23, 24]. 
Interestingly, only heme robustly induced NETs in combination with TNF priming (Fig. 
1D & S1A), as previously reported in sickle cell disease [33]. 
 To verify that NET formation is linked to hemolysis in vivo, we determined the 
heme concentrations in our patient cohort. Free heme correlated with NETs in 
plasma, further validating heme as the NET-inducing factor in malaria (Fig. 1E).  
 
Heme-induced NETs require oxidants and NE/PR3 mediated proteolysis 
There are different pathways for NET formation [34]. We tested the involvement of 
host factors previously implicated in NETosis, starting with the ROS-producing enzyme 
NOX2 [7].  We isolated neutrophils from patients with chronic granulomatous disease 
(CGD) (n=3), who carry NOX2 mutations, rendering them completely deficient in ROS 
production (Fig S1B). Heme induced similar levels of NETs in CGD and control 
neutrophils, unlike PMA, which failed to induce NETs in CGD cells (Fig 2A). Although 
this oxidase was not involved, heme-induced NETs required ROS signaling since 
treatment with the ROS scavenger pyrocatechol (Fig S1C) completely abolished 
NETosis (Fig 2B), suggesting that heme itself might be the oxidizing agent. In addition 
to oxidants, heme-triggered NETs required activity of protein kinase C (PKC) [35], 
cyclin dependent kinase 6 (CDK6) [5], and NE/PR3 [9] but were independent of 
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peptidyl arginine deiminase 4 (PAD4)-mediated citrullination [36] (Fig 2B). We also 
tested the requirement for de novo protein synthesis using the translational inhibitor 
cycloheximide. This drug, at a concentration that fully blocked synthesis of the cytokine 
IL-8 (Fig. S1D), had no effect on NET formation (Fig 2B), as previously reported for 
other stimuli [37]. 
To genetically confirm the role of proteases in heme NET induction, we purified 
peritoneal neutrophils from NE single and NE/PR3 double knockout mice. NE/PR3 -/- 
neutrophils failed to release extracellular chromatin, while NE -/- cells displayed a 
partial deficiency (Fig. 2C & D), demonstrating that these proteases have an essential 
non-redundant function in decondensing chromatin. In contrast, there was no 
difference in NET formation between PAD4 -/- and control neutrophils (Fig 2C & D).  
 
Soluble NET components drive malaria pathology in vivo 
To address the function of NETs in Plasmodium infections in vivo, we used NE/PR3  
-/- mice as a NET deficient model. Additionally, to investigate the effect of a failure to 
degrade NETs extracellularly we used DNase 1 -/- mice. In the absence of DNase 1, 
NETs are made normally (Fig. 2C & D) but they persist at sites of release because 
they are not processed into soluble components [4]. DNase 1 -/- animals are deficient 
in dispersal of NET components and are a model to study the systemic effects of NET-
associated alarmins. 
We infected mice with the erythrocytic stages of P. chabaudi, a rodent malaria 
parasite that causes a non-lethal, two-week acute infection. Similar to P. falciparum, 
P. chabaudi iRBCs synchronously sequester in organs and induce pathology [38, 39]. 
We quantified NETs in plasma by detecting soluble complexes of DNA and the 
granular protein myeloperoxidase (MPO). We chose this granular component over NE 
in order to enable us to analyze NETs in NE deficient mice. NET components (Fig 3A) 
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and extracellular nucleosomes (Fig. 3B) increased in infected WT mice but were 
completely absent in NE/PR3 and DNase 1 -/- mice. This result is consistent with a 
failure to produce NETs in the case of NE/PR3 -/- animals and with a failure to 
solubilize the NET macrostructure in the case of DNase 1 -/-.  Notably, parasitemia 
was similar in all three mouse strains (Fig. 3C), showing that NETs are not antiparasitic. 
As previously described [27, 38],  parasitemia peaked between day 9 and 11 and was 
suppressed by day 13 post infection. 
P. chabaudi sequesters in the liver and lungs where it induces tissue damage and 
immunopathology [38]. Livers from WT mice were severely darkened and discolored 
because of the accumulation of hemozoin and hepatocyte death (Fig. 3D). 
Remarkably, livers of infected NE/PR3 -/- and DNase 1 -/- mice were completely 
unaffected and indistinguishable from uninfected controls (Fig. 3D). Livers of WT, but 
not NE/PR3 or DNase1 -/- mice, showed necrosis and immune infiltration, 
characteristic malaria pathology, upon histological analysis of haematoxylin and eosin 
(H&E) stained sections (Fig. 3E and Fig. S2A). We confirmed the liver pathology in 
wild type, but not mutant mice, with the hepatic damage marker asparate 
aminotransferase (AST) in plasma (Fig. 3F). Tissue damage was also significantly 
reduced in lungs of NE/PR3 knockout mice (Fig. S3) compared to WT controls, 
although P. chabaudi causes only mild lung pathology [38].  These data demonstrate 
that release of components from NETs promotes organ pathology in malaria. 
 
Exogenous NET components restore pathology in NET-deficient mice 
To confirm that NETs are pathogenic in malaria, we injected mice with in vitro 
generated NET fragments. We chose NE/PR3 -/- as the NET-deficient strain in which 
to carry out this complementation experiment. We first purified peritoneal neutrophils 
from WT mice and induced them to form NETs. After washing, NETs were dislodged 
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by scraping and sonicated to obtain fragments, which were quantified and injected into 
the tail vein of control and P. chabaudi parasitized mice. Injection of NET fragments 
did not cause liver pathology in uninfected mice (Fig 3G) nor affect parasitemia in any 
of the infected genotypes (Fig. S4). Strikingly, restoring NET fragments in parasitized 
NE/PR3 -/- mice fully recapitulated the liver damage observed in WT mice (Fig 3G). 
This result demonstrates the direct pathogenicity of NETs and rules out a cell-
autonomous effect of proteases as the cause of the protective effect in the knockout 
animals. 
NETs contain multiple components with inflammatory activity [40]. These include 
the DNA backbone, as well as the protein fraction that contains many alarmins. 
Furthermore, extracellular nucleosomes and histones, which form a major portion of 
NETs, are inflammatory when found in the blood stream [41]. To identify which NET 
components are responsible for inducing pathology, we used recombinant DNase 1 to 
fully digest the DNA of the in vitro NET preparation, leaving only the protein 
components. Notably, the NET protein fraction was sufficient to induce liver damage 
in NE/PR3 null mice (Fig 3G). As a control, we also injected mouse nucleosomes 
purified from bone marrow derived macrophages, which failed to induce AST release 
after injection (Fig 3G). These data show that the pathogenic activity derives from 
either a NET-specific protein or a NET-specific protein modification.  
 
NETs induce emergency granulopoiesis via GCSF induction 
Neutrophils cause tissue destruction due to the cytotoxic molecules they carry. We 
quantified neutrophil infiltration into the livers of parasitized mice using 
immunofluorescence staining of the intracellular neutrophil marker calgranulin. 
Neutrophils accumulated in the livers of WT, but not NE/PR3 and DNase 1 -/- animals 
(Fig4 A and Fig. S5), consistent with neutrophils being initiators of hepatic pathology.  
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We quantified systemic neutrophil numbers to determine why both deficient mice 
genotypes failed to recruit neutrophils into the liver. In malaria, like other infections, the 
number of circulating neutrophils increases due to emergency granulopoiesis in the 
bone marrow [42-44]. We observed that P. chabaudi infection leads to neutrophilia in 
WT mice but not in NE/PR3 and DNase1 knockouts (Fig 4B). 
The major mediator of emergency granulopoiesis is GCSF [45]. We speculated that 
NETs directly induce GCSF. To test this, we stimulated macrophages - a significant 
physiological source of this cytokine - with NETs in vitro. NETs robustly induced 
production of GCSF in monocyte-derived human macrophages (Fig 4C). 
In P. chabaudi infected WT mice, the concentration of GCSF in plasma increased 
with rising parasitemia; however, there was no increase in either NE/PR3 or DNase 1 
-/- mice (Fig 4D). To directly demonstrate that NETs induce GCSF in vivo, we showed 
that injection of NET fragments fully restored GCSF production in NE/PR3 mice to 
levels seen in WT mice (Fig 4E). As with the liver damage marker AST, GCSF 
production was induced by the protein component of NETs, as complete removal of 
DNA prior to injection did not abrogate the effect. These data show that NET-
associated alarmins drive emergency hematopoiesis by inducing GCSF release. 
 
NETs promote parasite sequestration in organs 
Malaria tissue pathology is linked to parasite sequestration in the microvasculature of 
afflicted organs. The lack of discoloration in livers of infected NE/PR3 and DNase 1 -/- 
mice (Fig 3D) suggests a lack of parasite adhesion. To directly analyze sequestration, 
we infected mice with a luciferase-expressing strain of P. chabaudi [38] and quantified 
parasite load in organs after perfusing animals to remove unbound, freely-circulating 
parasites.  
 11 
As reported, P. chabaudi sequestered most prominently in the liver and the lung and, 
to a lesser degree, in the kidneys [38]. Remarkably, there were tenfold fewer 
parasites sequestered in the livers and lungs of NE/PR3 and DNAse 1 -/- mice 
compared to WT controls (Fig 5A). We confirmed this sequestration pattern by 
histological enumeration of schizonts in the liver microvasculature (Fig. 5B and Fig. 
S2B) as well as by electron microscopy  (Fig. S2C). 
 
NETs induce upregulation of ICAM-1 
The difference in abundance of neutrophils in livers of WT and knockout animals was 
greater than the difference observed in peripheral blood, indicating that, in addition to 
emergency granulopoiesis, NETs regulate neutrophil trafficking. Interestingly, both 
neutrophils [46] and parasites [47, 48] use the same receptor to dock to endothelial 
cells: intercellular adhesion molecule 1 (ICAM-1). We analyzed entire liver sections 
by immunofluorescence and observed upregulation of ICAM-1 in infected WT but not 
NE/PR3 or DNase1 -/- mice, coinciding with the onset of liver damage (Fig. 5C). We 
also measured soluble ICAM-1 in plasma by ELISA and found no induction of this 
adhesion receptor in NE/PR3 -/- compared to WT animals (Fig. 5D), confirming our 
microscopy results. Injecting in vitro generated NET fragments into parasitized 
NE/PR3 -/- mice restored the expression of ICAM-1 (Fig. 5D), demonstrating that 
NET components control ICAM-1 expression. 
 
Neutralizing GCSF antibodies decrease liver damage  
To test whether GCSF-induced neutrophilia is pathogenic, we injected parasitized 
animals with an anti-GCSF antibody two days before the parasitemia peak. The 
neutralizing antibody significantly decreased liver damage compared to the isotype 
control (Fig. 6B). As expected, the treatment did not impact parasite burden (Fig. 6A). 
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Notably, the GCSF concentration in plasma of malaria patients is significantly 
increased in infected individuals (Fig 6C), as previously reported [49]. Interfering with 
GCSF signaling can therefore alleviate malaria pathology.  
 
 
 
Discussion 
 
Malaria pathophysiology is based on an interplay of parasite proliferation, host 
inflammatory response and microvascular obstruction due to binding of iRBCs to 
activated endothelia. Despite important recent advances [16, 17, 24, 27, 30], the 
contribution of neutrophils to these processes remains poorly characterized. Here we 
demonstrate that neutrophils play an essential role in both propagation of 
inflammation and facilitation of parasite cytoadherence. 
Firstly, we showed that in malaria, as in sickle-cell disease [33], extracellular heme 
triggers NETosis in TNF-primed neutrophils. Heme-induced NETs require some of 
the same signaling intermediates demonstrated for other NET inducers, including 
neutrophil proteases [8], CDK6 [5] and PKC [35]. Heme is known to activate PKC in 
neutrophils, initiating chemotaxis and IL-8 production [50]. TNF priming thus provides 
a synergistic signal required for NETosis; this signal is posttranslational, since it is 
not blocked by the translational inhibitor cycloheximide. Heme-induced NETs are 
independent of the citrullinating enzyme PAD4, which is implicated in ionophore-
induced NETs [36] and of the oxidant-generating enzyme NOX2 [34], which is known 
to be suppressed in neutrophils from malaria patients [24]. ROS signaling is 
nevertheless required for heme NETs, as the response is blocked by the ROS 
scavenger pyrocathecol. This may be due to the fact that heme is itself a redox-
active molecule, with multiple mechanisms for initiating and propagating free radicals 
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[51]. In summary, heme utilizes a unique pathway for NET induction that 
nevertheless requires both protease activity and ROS signaling. 
NETs are essential for malaria pathology in the P. chabaudi model. We showed 
that solubilization of NETs by serum Dnase 1 liberates immunostimulatory 
components that diffuse systemically and are pathogenic via two mechanisms. The 
first is induction of GCSF in macrophages, which initiates emergency granulopoiesis. 
This corresponds to what is seen in patients, where GCSF is elevated in both P. 
falciparum [49] and P. vivax infections [52]. Moreover, neutrophil turnover is often 
higher in malaria [42-44] and, in children living in endemic areas, increased 
neutrophil counts correlate with symptoms of severe disease, such as prostration, 
coma and respiratory distress [53-55]. In a second mechanism, NET components 
upregulate ICAM-1, a key cytoadhesion receptor that sequesters parasitized RBCs in 
the microvasculature [47, 48]. Interestingly, in P. falciparum malaria, ICAM-1 
mediates cytoadhesion in the brain and is a key mediator of cerebral malaria [48, 56]. 
Antibodies against ICAM-1 binding variants of P. falciparum Erythrocyte Membrane 
Protein 1 (PfEMP1), the main parasite cytoadhesion factor, protect against clinical 
disease [57, 58]. NET induction of ICAM-1, which facilitates P. chabaudi adhesion in 
the liver, may thus operate in human malaria to recruit P. falciparum iRBCs to the 
brain, a far more dangerous sequestration site. This is consistent with recent reports 
showing an association between neutrophil proteins and cerebral malaria [16, 26]. 
NET components are also required for pathology and P. chabaudi sequestration in 
the lungs, demonstrating that this mechanism may be broadly generalizable to 
different vascular beds. Respiratory distress significantly contributes to morbidity and 
mortality of malaria. Furthermore, in the P. chabaudi model, lung sequestration is 
mediated by an unidentified receptor other than ICAM-1 [47], indicating that NET 
components may be upregulating more than one cytoadhesion molecule. 
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Our data demonstrate the essential role of DNAse 1 in releasing pathogenic NET 
fragments in malaria. NETs are thought to be anchored to the endothelium after 
release [59, 60], through von Willebrand factor [59] and probably other mediators.  
Serum DNAse 1 allows systemic diffusion of NET components, as demonstrated by 
absence of NET fragments in DNase 1 knockouts. A similar pathogenic function of 
DNAse 1 was shown in a polymicrobial sepsis model, where injection of recombinant 
DNase 1 promotes liver damage and neutrophil accumulation in liver and lung [61].  
However, DNase 1 has contradictory roles in inflammation; in thrombosis [62, 63], 
cancer [64] and SLE [4], this endonuclease is protective rather than pathogenic. In 
non-microbial inflammation it is therefore the unprocessed NET ‘macrostructure’ that 
is detrimental, while in infections such as malaria and sepsis, it is the discrete 
molecular components of NETs that cause disease.  
The NET proteins that induce GCSF and ICAM-1 remain unknown. Many 
proteins found on NETs are classified as alarmins [65]; including α-defensins, 
cathelicidin, calgranulin and lactoferrin [66]. Once released, these alarmins can 
induce maturation and activation of other immune cells such as dendritic cells, T 
cells, macrophages and endothelial cells [65]. Additional experiments will determine 
which molecules are responsible for triggering granulopoiesis and endothelial 
activation.  
NET-associated molecules are necessary but not sufficient to drive inflammation in 
malaria, as shown by the injection of NET fragments into uninfected mice. Additional 
stimuli, most likely Plasmodium PAMPs or DAMPs [23] are required to initiate 
emergency hematopoiesis and liver damage. Furthermore, inflammation in malaria is 
complex with type-I interferons [27], CD8+ T cells [38, 67] and hemostasis [68] 
contributing to immunopathogenesis. Further work is required to understand how 
neutrophils crosstalk with other cell types in initiating disease. 
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Malaria exerts an evolutionary selective pressure on populations living in endemic 
areas, selecting for gene variants that promote tolerance [69]. Interestingly, people of 
African descent and some ethnic groups from the Middle East, have low neutrophil 
counts [70]. This “ethnic or benign neutropenia” could be the result of selective 
pressure to suppress neutrophil counts since they are detrimental in this disease. 
Strikingly, in addition to Duffy antigen, the loci linked to ethnic neutropenias include  
CDK6 and GCSF [71], both of which are directly involved in the NET-mediated 
pathogenic mechanism described here. 
Recent studies confirmed the central role of heme in the pathophysiology of 
malaria [72]. Moreover, extracellular heme accumulation is not limited to malaria; it is 
a confirmed pathogenic factor in sepsis, sickle cell disease, intracerebral hemorrhage 
and atherosclerosis [51],  all of which also have reported neutrophil involvement. It 
would therefore be interesting to examine if emergency hematopoiesis and 
endothelial activation triggered by NET fragments are universal outcomes in 
intravascular hemolytic diseases. 
Adjunctive therapies that treat the life-threatening complications of malaria are 
urgently needed. We show that NETs control inflammation and parasite 
cytoadherence, placing neutrophils at the nexus of malaria pathophysiology and 
identifying them as a potential target for adjunctive therapy. 
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Materials and Methods 
 
Antibodies, staining reagents, stimuli and inhibitors 
 
Anti-human-NE-Biotin (Ab79962, abcam), anti-mouse-MPO-Biotin (HM1051BT, 
Hycult), anti-DNA-POD (Cell Death Detection ELISA Kit, Roche), anti-mouse-ICAM 
(AF796, Novus Biologicals), anti-mouse-Calgranulin (MPIIB, in house), anti-chromatin 
(PL2-3, [73]), Hoechst (639, Immunochemistry), PMA (P8139, Sigma), Heme (H651-
9, Frontier Scientific), murine TNF (315-01A, Peprotech), human TNF (300-01A, 
Peprotech), PKC inhibitor (Go6976, Tocris), pyrocatechol (C9510, Sigma), 
Cycloheximide (Sigma-Aldrich), Cdk4/6 inhibitor (LY2835219, Selleck), PAD4 inhibitor 
(TDFA, Tocris), NE inhibitor (GW311616A, Sigma-Aldrich), Luminol (11050, AAT-
Bioquest), horse radish peroxidase (HRP, 31941, Serva), Bright-Glo Luciferase 
Substrate (E2610, Promega) 
 
ELISA Kits 
Cell Death Detection ELISA Plus (11920685001, Roche Diagnostics), Human 
Interleukin 8 Quantikine ELISA (S8000C, R&D Systems), mouse GCSF Quantikine 
ELISA (MCS00, R&D Systems), human GCSF Quantikine ELISA (SCS50, R&D 
Systems), mouse ICAM-1 ELISA (DY796, R&D Systems) 
 
Human samples 
Our study was conducted in accordance with the Helsinki Declaration. Blood 
donations from healthy donors and CGD patients were collected after obtaining 
informed consent. Histopathological brain samples were collected anonymously at 
Charité University Hospital, Berlin, from autopsies of travellers returning from malaria 
endemic areas. Both blood and pathology sample collection was approved by the 
ethical committee of Charité University Hospital, Berlin, Germany. 
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Collection of blood from malaria patients was approved by the Comité d'Ethique 
Régional Indépendent de Lambaréné in Gabon. All study participants provided 
written informed consent before being enrolled in the study. 
 
Mice 
Mouse breeding, infections and isolation of peritoneal neutrophils were approved by 
the Berlin state authority Landesamt für Gesundheit und Soziales. Animals were bred 
at the Max Planck Institute for Infection Biology. Mice were housed in specific pathogen 
free (SPF) conditions, maintained on a 12-hour light/dark cycle and fed ad libitum. NE 
-/- were decribed here [74]  and NE/PR3 -/- mice here [75] PAD4 -/- [76] were a kind 
gift of Denisa Wagner.  Production of Dnase 1 -/- mice will be described shortly (Kenny 
et al, submitted).   
 
Human Neutrophil isolation and stimulation  
Cells were purified by a first centrifugation of whole blood over Histopaque-1119 
(Sigma) followed by a discontinuous Percoll gradient (20). All experiments were done 
in RPMI-1640 (w/o phenol red, Gibco) supplemented with 10mM HEPES and 0.05% 
human serum albumin. 105 Cells were seeded onto glass coverslips in a 24 well plate 
and incubated with inhibitors for 30 min, followed by 15 min priming with TNF and 
addition of the stimuli.  
 
Luminol assay  
To assess ROS production, 1x106 neutrophils were activated (after treatment with 
inhibitors/ ROS scavengers) with 100 nM PMA. ROS production was measured by 
monitoring luminol (50 µM) luminescence in the presence of 1.2U/ml horseradish 
peroxidase. 
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Mouse neutrophil isolation and stimulation 
Murine neutrophils were isolated from peritoneal cavities of WT, NE -/-, NE/PR3 -/-, 
PAD4 -/- and DNase1 -/- mutant animals after injection of casein (Sigma) 
intraperitoneally by centrifugation over Percoll [77].  
Cells were seeded onto glass coverslips at 105/well in 24 well plates in RPMI (Gibco) 
containing penicillin/streptomycin (Gibco) and glutamine (Gibco), 1% murine DNase 1 
-/- serum and 100 ng/ml murine G-CSF (Peprotech). After 30 min settling and 15 min 
TNF priming, cells were stimulated with 100 nM PMA or 20 µM heme. NETs were 
quantified after 18 hours stimulation 
 
Quantification of NET formation 
 
The quantification of NETosis was carried out as previously described [78]. Briefly, 
cells were fixed for 30 minutes at room temperature in 2 % paraformaldehyde (PFA), 
permeabilized with 0.5 % Triton-X100 and blocked for 30 minutes in blocking buffer. 
Cells were then stained with the anti-neutrophil elastase antibody (see above) and 
antibody directed against the subnucleosomal complex of Histone 2A, Histone 2B and 
chromatin [73], as well as secondary antibodies goat anti-mouse Alexa Fluor 568, goat 
anti-rabbit Alexa Fluor 488 and Hoechst 33342 (Sigma-Aldrich). Samples were 
mounted on coverslips with Mowiol. Image acquisition was done using a Leica DMR 
upright fluorescence microscope equipped with a Jenoptic B/W digital microscope 
camera and analyzed using ImageJ/FIJI software. 
 
Heme preparation 
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Heme for in vitro stimulation of neutrophils and for standard curve was prepared fresh 
on the day of the experiment. 10 mM stock solution was prepared by dissolving 0.0325 
g Hemin (H651-9, Frontier Scientific) in 5 ml DMSO. 
 
Quantification of plasma heme  
 
Heme was quantified using the formic acid assay [79]. Briefly, samples were diluted 
1:50 in H2O in white 96 well plates. The heme concentration was determined after the 
addition of formic acid (150 µL/well, 100 %, Merck) to all samples and absorbance 
measurement at 405nm using a microplate reader. Measurements were compared to 
a hemin standard curve in the range of 0.25 – 16 µM in H2O.  
 
P. falciparum culture 
P. falciparum parasites were cultured using standard procedures as described 
previously [80] . Parasites were grown at 5% hematocrit in RPMI 1640 medium, 0.5% 
AlbuMax II (Invitrogen), 0.25% sodium bicarbonate, and 0.1 mg/ml gentamicin. 
Cultures were incubated at 37°C in an atmosphere of 5% oxygen, 5% carbon dioxide, 
and 90% nitrogen.  
 
Trophozoite and merozoite preparation 
The mature-stage P. falciparum culture was washed and taken up in 2 ml of RPMI and 
layered onto 5 ml of a 60% Percoll solution. The mixture was centrifuged and 
trophozoites were collected at the interphase between RPMI and Percoll, while 
uninfected RBCs and ring stage infected RBCs were pelleted. Parasites were washed 
three times with RPMI and iRBCs were pelleted. For merozoite isolation iRBCs were 
lysed with 0.03 % saponin solution. Subsequently the sample was centrifuged, washed 
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three times with PBS and taken up in RPMI. Concentration of merozoites was 
determined by use of a Neubauer chamber. 
 
Isolation of digestive vacuoles from P. falciparum  
Late trophozoite cultures with 10 % parasitemia were first exposed to saponin (0.5 
µg/ml) lysis, washed in PBS and parasites were then lysed in ice-cold H2O and by 
passage through a 27 G needle. This preparation was spun down, resuspended in 
uptake buffer (pH 7.4, 2mM MgSO4, 100 mM KCl, 25 mM HEPES, 25 mM NaHCO3 
and 5mM Na3PO4) and separated by density using 42 % Percoll. The DV could be 
collected at the bottom, washed and used in subsequent experiments. 
 
P. chabaudi infection, plasma and tissue preparation  
Male mice aged 8-15 weeks of all genotypes were infected by intravenous injection of 
viable P. chabaudi AS parasites (WT) or PccASluc (luciferase-expressing; [38]). To 
ensure viability of the parasites, a frozen aliquot was thawed and injected 
intraperitoneally (i.p.) into a transfer mouse. The number injected into each mouse was 
adjusted according to body weight so that every animal received 1x104 iRBCs per 20 
g. 
Parasitemia of infected mice was monitored from day 5 post infection onward every 48 
hours by Giemsa-stained thin blood smear.  
Mice were bled by cardiac puncture under non-recovery deep anesthesia.  Blood was 
kept from coagulating by addition of 50 µM final concentration of EDTA. Plasma was 
generated by centrifugation at 10,000 x g at 4°C for 10 minutes. Plasma was aliquoted, 
snap frozen in liquid nitrogen and stored at -80°C until further use. Plasma was always 
thawed on ice. 
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 Organs were harvested without additional perfusion (except in parasite sequestration 
experiments) as blood was removed by terminal bleeding of the animals.  The organs 
were fixed for 20h at room temperature in 2% PFA.  
 
Immunohistochemistry 
 
The blinded scoring of liver pathology as well as the counting of parasites sequestered 
in the microvasculature of the livers was performed by trained pathologists at the 
iPATH-Berlin Core Unit for immunopathology of experimental model organisms from 
H&E stained Paraffin sections of 1 µm thickness. 
  
The scores were defined as follows: 
Hepatitis (Malaria)    
Modified according to [81]. 
 
      
Histopathologic 
changes 
Histopathologic grading 
  
0 1 2 3   
Fatty change No fatty change < 10% 10-50% > 50%   
Kupffer 
cells/HPF < 20/HPF 20-35/HPF 36-50/HPF > 50/HPF   
Portal tract 
inflammation 
< 5% of 
portal tract 
area 
5-15% of 
portal tract 
area 
16-30% of 
portal tract 
area 
> 30% of 
portal tract 
area   
Bile duct 
proliferation 
No 
proliferation 
Mild 
proliferation 
Moderate 
proliferation 
Severe 
proliferation   
Sinusoid 
congestion 
No 
congestion 
Mild 
congestion 
Moderate 
congestion 
Severe 
congestion   
Haemozoin 
deposition 
No 
deposition 
Mild 
deposition 
Moderate 
deposition 
Severe 
deposition   
Necrosis none <10% 11-25% >25%   
 
Acute Lung injury 
Modified according to [82]. 
 
0, thin and delicate alveolar septae, no intra-alveolar fibrin strands 
or hyaline membranes and <5 intra-alveolar cells, no perivascular  
or peribronchial infiltrates 
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1, mildly congested alveolar septae, few fibrin strands or hyaline 
membranes  
and <10 intra-alveolar cells with mild perivascular and/or 
peribronchial infiltration 
2, moderately congested alveolar septae, some fibrin strands or 
hyaline  
membranes, <20 intra-alveolar cells with moderate perivascular 
and/or  
peribronchial infiltration 
3, severely congested alveolar septae, many fibrin strands and 
presence  
of hyaline membranes, >20 intra-alveolar cells with severe 
perivascular  
and/or peribronchial infiltration 
 
 
Immunofluorescence of tissue sections 
 
Mouse tissue was fixed in 2% paraformaldehyde solution in Tris-buffered saline (TBS, 
pH 7.4) for 20 hours at room temperature. The tissue was then dehydrated and 
paraffin-embedded (60°C) using a Leica TP 1020 tissue processor.  
Paraffin blocks of both mouse and human samples were cut to 3 μm and sections were 
mounted and dried on Superfrost Plus slides (Thermo Scientific) avoiding 
temperatures above 37°C. After dewaxing and rehydration, sections were incubated in 
HIER buffer pH6 (citrate buffer) [20 minutes at 96°C in a steam cooker (Braun)]. 
After antigen retrieval, sections were left in the respective HIER buffer at room 
temperature to cool below 30°C, rinsed three times with deionized water and once with 
PBS pH 7.4, and permeabilized for five minutes with 0.5% Triton-X100 in PBS at room 
temperature, followed by three rinsing steps with PBS. 
Sections were surrounded with PAP-pen and treated with blocking buffer for 30 
minutes to prevent non-specific binding. Primary antibodies were diluted in blocking 
buffer and incubated on the sections over night at room temperature. We used 
secondary antibodies raised in donkey and pre-absorbed against serum proteins from 
multiple host species (Jackson Immuno Research). Dilution and blocking was done in 
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PBS supplemented with 1% BSA, 2% donkey normal serum, 5% cold water fish 
gelatin, 0.05% Tween 20 and 0.05%Triton X100. 
Slides were mounted using Mowiol and digitized with a ZEISS AxiosScan.Z1. This is 
an automated microscope that generates a series of overlapping photographs which 
are assembled to a single image of a complete organ section. Using the software 
package Volocity 6.3 the tissue area positive for Calgranulin A and ICAM-1 was 
determined and expressed as percentage of the total tissue area of the respective 
section. 
 
NET ELISA  
NETs in circulation were determined as NE/DNA complexes in human samples and 
MPO/DNA complexes in mouse samples. For the mouse ELISA; the biotinylated 
primary AB mouse-MPO (1µg/ml final concentration) was coated onto a streptavidin 
coated plate at 4°C over night and the plates were blocked for 2h with 1 % BSA in 
PBS. For the human ELISA we used the precoated and blocked plates of the Hycult 
human NE ELISA (HK319-02). Samples were incubated for 2h at room temperature 
with 350 rpm agitation. The anti-DNA-POD antibody was diluted 1:100; plate was 
incubated for 2h at room temperature, followed by signal development using TMB 
substrate and H2SO4 stopping. Signal was acquired at 450 nm.  
 
Determination of liver enzyme concentration in mouse plasma  
 
The concentration of the hepatocyte specific enzyme aspartate-aminotransferase in 
the plasma of experimental animals were determined by the routine veterinarian 
service laboratory at SYNLAB.vet GmbH (Turmstraße 21, 10559 Berlin). 
 
FACS analysis of mouse whole blood  
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100 µl of mouse whole blood were stained directly by addition of 100 µl of FACS 
antibodies diluted 1:100 in PBS (2.5 % FCS, 0.1 % NaN3) for 30 minutes. Cells were 
treated with 3 ml 1-Step Fix/Lyse (00-5333-54) for 60 min at room temperature, spun 
down, washed and taken up in 250 µl FACS buffer prior to analysis using a 
MACSQuant Analyser.  
Antibodies all from BD: V500 anti-CD45 (561487), FITC anti-CD3(561798), APC anti-
CD8a (561093), PECy7 anti-CD4 (552775), PE anti-CD115 (565249), PerCP-Cy5.5 
anti-Ly6G/C (561103)  
 
Assessment of sequestration of luciferase-expressing parasites 
Mice were infected with a luciferase-expressing strain of P. chabaudi (PccASluc [38]) 
as described above but kept on a reverse light cycle, as sequestration occurs during 
the dark cycle [38]. At the time of maximum sequestration (12.00 – 14.00 h coordinated 
universal time (UCT), reverse light) mice were sacrificed and perfused systemically by 
injection of 10 ml PBS into the heart. Organs were harvested and 0.1 g of tissue was 
transferred to a Precellys homogenizer tube in PBS and dissociated for one cycle, 10 
seconds at 4500 rpm in a Precellys Evolution Homogenizer. The sample was then 
diluted 1:10 in PBS, and an equal volume of Bright-Glo substrate (Promega, 100 µL) 
was added. Luciferase activity was measured after 2 min incubation using a Perkin 
Elmer VICTOR X Light Multilabel Plate Reader. 
 
Injection of exogenous NETs 
 
Murine NETs were prepared from WT peritoneal neutrophils as described above, 
washed twice with PBS to remove residual PMA, scraped from the plate and sonicated 
for 15 seconds at 70 % Power using a Bandelin SONOPLUS sonicator. DNA 
concentration was quantified by PicoGreen assay (P11496, Thermo Fisher Scientific) 
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and NanoDrop measurements . Where applicable sample was then treated with 2 U 
DNase 1 from TURBO DNA-free Kit (AM1907, ThermoFisher Scientific) overnight at 
37°C. The kit was chosen because it contains a DNase inactivating agent, which was 
used according to manufacturers specifications to ensure that no DNase activity was 
introduce into injected mice. Complete digestion of DNA was confirmed both by 
agarose gel electrophoresis and PicoGreen measurement. Mice were injected with an 
amount of NETs and chromatin previously observed to have accumulated in infected 
WT mice, which was 300 ng/ml of blood. We assumed a blood volume of an adult male 
mouse of 1.5 ml and therefore injected 450 ng of either NETs or chromatin into each 
mouse. 
 
Chromatin was isolated from bone marrow derived macrophages, which were 
prepared according to standard protocol [83] and chromatin was prepared as 
previously described [84]. Briefly, when cells were confluent they were harvested, 
washed and counted, per 5 x 106 cells 300 µl of hypotonic buffer A (10 mM HEPES, 
pH 7.5, 10 mM KCl, 3 mM NaCl, 3mM MgCl2, 1 mM EDTA, mM EGTA and 2 mM 
dithiothreitol and a general protease inhibitor cocktail (78430, ThermoFisher 
Scientific)) was added and incubated on ice for 15 minutes. Subsequently 0.05 
volumes of 10 % Nonidet P-40 were added, the cells were vortexed and centrifuged at 
500 x g for 10 minutes at 4°C. The supernatant was discarded, the nuclei in the pellet 
washed in buffer A and subsequently resuspended in 50 µl of ice-cold buffer NE (20 
mM HEPES, pH 7.5, 25 % glycerol, 0.8 mM KCl, 1mM MgCl2, 1 % Nonidet P-40, 05. 
mM EDTA, 2 mM dithiothreitol). Following a 20 minutes incubation on ice with 
occasional mixing the samples were centrifuged at 14,000 x g for 15 minutes at 4°C. 
The supernatant was discarded and the pellet containing the chromatin resuspended 
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in ddH2O. Chromatin concentration was determined by Picogreen assay (see above) 
and samples were stored at -80°C. 
 
Macrophage stimulation with NETs 
Monocytes were isolated by magnetic CD14 positive selection (130-050-201, Miltenyi 
Biotec) and differentiated for 7 days into macrophages in RPMI 1640 containing P/S, 
Glutamine and 5 ng/ml human MCSF. At the day of the experiment, 3x106 neutrophils 
were stimulated for 4 h with 100 nM PMA. The resulting NETs were washed three 
times with PBS, harvested by scraping and sonicated. The NET concentration was 
determined by Picogreen assay. Macrophages were stimulated for 12 h with 1 µg/ml 
isolated NETs. Supernatants were collected and GCSF was quantified by ELISA. 
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